Macugen is the latest treatment now approved in Canada to treat macular degeneration

Macugen is the latest treatment now approved in Canada to treat macular degeneration.

Macular degeneration is a main cause of blindness in the elderly. The "wet" form is less common than the "dry" form...but it's more severe. Treatments are only available for the wet form.

Macugen (pegaptanib) stops the formation of new and leaky blood vessels in the macula.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote